ILMN
Price
$116.69
Change
-$1.60 (-1.35%)
Updated
Apr 18, 6:59 PM EST
13 days until earnings call
PEN
Price
$201.98
Change
-$6.75 (-3.23%)
Updated
Apr 18, 6:59 PM EST
18 days until earnings call
Ad is loading...

Compare trend and price ILMN vs PEN

Header iconILMN vs PEN Comparison
Open Charts ILMN vs PENBanner chart's image
Illumina
Price$116.69
Change-$1.60 (-1.35%)
Volume$881.25K
CapitalizationN/A
Penumbra
Price$201.98
Change-$6.75 (-3.23%)
Volume$108.44K
CapitalizationN/A
View a ticker or compare two or three
ILMN vs PEN Comparison Chart

Loading...

ILMNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ILMN vs. PEN commentary
Apr 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ILMN is a StrongBuy and PEN is a Hold.

COMPARISON
Comparison
Apr 19, 2024
Stock price -- (ILMN: $116.69 vs. PEN: $201.84)
Brand notoriety: ILMN: Notable vs. PEN: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ILMN: 111% vs. PEN: 88%
Market capitalization -- ILMN: $21.09B vs. PEN: $8.64B
ILMN [@Medical Specialties] is valued at $21.09B. PEN’s [@Medical Specialties] market capitalization is $8.64B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ILMN’s FA Score shows that 0 FA rating(s) are green whilePEN’s FA Score has 0 green FA rating(s).

  • ILMN’s FA Score: 0 green, 5 red.
  • PEN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ILMN and PEN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ILMN’s TA Score shows that 4 TA indicator(s) are bullish while PEN’s TA Score has 4 bullish TA indicator(s).

  • ILMN’s TA Score: 4 bullish, 5 bearish.
  • PEN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PEN is a better buy in the short-term than ILMN.

Price Growth

ILMN (@Medical Specialties) experienced а -10.72% price change this week, while PEN (@Medical Specialties) price change was -9.27% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.63%. For the same industry, the average monthly price growth was -3.78%, and the average quarterly price growth was +9.66%.

Reported Earning Dates

ILMN is expected to report earnings on Aug 08, 2024.

PEN is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Medical Specialties (-3.63% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ILMN with price predictions.
OPEN
A.I.dvisor published
a Summary for PEN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ILMN($21.1B) has a higher market cap than PEN($8.64B). PEN has higher P/E ratio than ILMN: PEN (93.70) vs ILMN (49.50). ILMN YTD gains are higher at: -16.195 vs. PEN (-19.758). PEN has higher annual earnings (EBITDA): 109M vs. ILMN (-608M). ILMN has more cash in the bank: 1.05B vs. PEN (289M). PEN has less debt than ILMN: PEN (234M) vs ILMN (2.26B). ILMN has higher revenues than PEN: ILMN (4.5B) vs PEN (1.06B).
ILMNPENILMN / PEN
Capitalization21.1B8.64B244%
EBITDA-608M109M-558%
Gain YTD-16.195-19.75882%
P/E Ratio49.5093.7053%
Revenue4.5B1.06B425%
Total Cash1.05B289M365%
Total Debt2.26B234M967%
FUNDAMENTALS RATINGS
ILMN vs PEN: Fundamental Ratings
ILMN
PEN
OUTLOOK RATING
1..100
6363
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
10067
SMR RATING
1..100
9577
PRICE GROWTH RATING
1..100
6464
P/E GROWTH RATING
1..100
9099
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ILMN's Valuation (83) in the Biotechnology industry is in the same range as PEN (92) in the Medical Specialties industry. This means that ILMN’s stock grew similarly to PEN’s over the last 12 months.

PEN's Profit vs Risk Rating (67) in the Medical Specialties industry is somewhat better than the same rating for ILMN (100) in the Biotechnology industry. This means that PEN’s stock grew somewhat faster than ILMN’s over the last 12 months.

PEN's SMR Rating (77) in the Medical Specialties industry is in the same range as ILMN (95) in the Biotechnology industry. This means that PEN’s stock grew similarly to ILMN’s over the last 12 months.

PEN's Price Growth Rating (64) in the Medical Specialties industry is in the same range as ILMN (64) in the Biotechnology industry. This means that PEN’s stock grew similarly to ILMN’s over the last 12 months.

ILMN's P/E Growth Rating (90) in the Biotechnology industry is in the same range as PEN (99) in the Medical Specialties industry. This means that ILMN’s stock grew similarly to PEN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ILMNPEN
RSI
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 30 days ago
68%
Bullish Trend 24 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 1 day ago
69%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
73%
Bearish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
ILMNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
PENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BURU0.17N/A
+2.98%
Nuburu
AXR22.170.58
+2.69%
AMREP Corp
REG57.760.47
+0.82%
Regency Centers Corp
CMPR88.33-1.90
-2.11%
Cimpress plc
LNZA2.89-0.17
-5.56%
LanzaTech Global

ILMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ILMN has been loosely correlated with RVTY. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ILMN jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ILMN
1D Price
Change %
ILMN100%
-1.35%
RVTY - ILMN
59%
Loosely correlated
-1.09%
BRKR - ILMN
56%
Loosely correlated
-5.28%
IQV - ILMN
50%
Loosely correlated
-0.04%
CRL - ILMN
49%
Loosely correlated
-1.10%
TMCI - ILMN
48%
Loosely correlated
-1.14%
More